9H5-20009-10284
1 vaccination
6 coded responses
12 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 693 / NE
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Moderna
- 2020-12-22
- 2020-12-24
- 2020-12-25
-
2020-12-26
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: Attributed to exhaustion due to holidayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-27
- 2020-12-29
-
2021-01-05
Survey response — day 14, dose 1MedDRA: Fatigue, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth, Skin disorder — Feeling: GoodFree text: Red, warm, sore, swollen, and somewhat itchy injection site about 7-8 days after injection. Extreme fatigue x 1 day at onset of the skin changes. Lasted 3-4 days then resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — day 21, dose 1MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore theoat, runny nose, nasal congestion, mild coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — day 28, dose 1MedDRA: Cough, Dyspnoea, Exposure to SARS-CoV-2, Fatigue, Headache, Nasal congestion, Oropharyngeal pain, Pain, Pleuritic pain, Rhinorrhoea — Feeling: Poor · Be unable to workFree text: Headache, nasal congestion, runny nose, SOB, dry cough, pleuritic chest pain, body aches, fatigue, sore throat. Suspect COVID-19 infxn as husband tested positive.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — day 35, dose 1MedDRA: Ageusia, Anosmia, Fatigue, Somnolence — Feeling: FairFree text: Loss of taste and smell, fatigue, somnolence.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
-
2021-12-24
Survey response — 12 months, dose 1MedDRA: Fatigue, Headache, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tested positive for covid 19 on 12/14. Headache, fatigue, nasal congestion, runny nose.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Moderna |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Attributed to exhaustion due to holiday
Release 1 — day 14, dose 1
Symptoms: Red, warm, sore, swollen, and somewhat itchy injection site about 7-8 days after injection. Extreme fatigue x 1 day at onset of the skin changes. Lasted 3-4 days then resolved.
Release 1 — day 21, dose 1
Symptoms: Sore theoat, runny nose, nasal congestion, mild cough
Release 2 — day 28, dose 1
Symptoms: Headache, nasal congestion, runny nose, SOB, dry cough, pleuritic chest pain, body aches, fatigue, sore throat. Suspect COVID-19 infxn as husband tested positive.
Release 2 — day 35, dose 1
Symptoms: Loss of taste and smell, fatigue, somnolence.
Release 10 — 12 months, dose 1
Symptoms: Tested positive for covid 19 on 12/14. Headache, fatigue, nasal congestion, runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pleuritic pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Skin disorder | ✓ | ✓ | ✓ |
| SD | Somnolence | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release